Subjects who are pregnant will not be eligible to take part in the study as levetiracetam and lamotrigine are classified as Pregnancy Category C drugs and may pose risk to the fetus Women of childbearing potential will have a urine pregnancy test prior to participation in the study The urine pregnancy test will be repeated at the final study visit Subjects with epilepsy who are of childbearing potential must use acceptable methods of birth control during the study to be continued until one month after discontinuation of the study drug If a subject does become pregnant during this time period she must notify the investigators 